Wordt geladen...
Miliary Tuberculosis in a Crohn's Disease Patient: The Risk beyond the Screening
Tumor necrosis factor alpha (TNFα) antagonist is recognized as an effective treatment to achieve clinical remission and healing mucosal in patients with moderate to severe active Crohn's disease. Considering that it plays a central role in immune-mediated modulation, there are some obvious conc...
Bewaard in:
| Gepubliceerd in: | GE Port J Gastroenterol |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
S. Karger AG
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6341350/ https://ncbi.nlm.nih.gov/pubmed/30675506 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000487297 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|